Jury Brandolini

Jury Brandolini

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in Journal of Thoracic Disease
Verified
Journal Article
Closed access
PDF file
JBJury Brandolini
Jury Brandolini
Luca BertolacciniLuca Bertolaccini
Luca Bertolaccini
APAlessandro Pardolesi
Alessandro Pardolesi
MSMaurizio Salvi
Maurizio Salvi
MVMirca Valli
Mirca Valli
PSPiergiorgio Solli
Piergiorgio Solli
Chondroblastoma is an uncommon benign bone tumour arising typically in the epiphysis. Few cases of chondroblastoma of the rib have been reported in the literature. We describe a case of chondroblastoma of a 47-year-old man located in the body of the IX right rib. The patient presented a moderate right thoracic pain with an apparently palpable mass. Computed tomography (CT) scan showed a well-defined oval 49 mm × 43 mm lesion with the lytic bone destruction of the rib. A surgical resection was performed with an excellent outcome and no recurrence after 4-year follow-up. We also conducted a systematic review of literature where we evidenced that chondroblastoma could affect people of all age, but it’s most common in children and young adult. Surgical resection constitutes the treatment of choice.

1 January 2017 in Shanghai Chest
Verified
Journal Article
Closed access
PDF file
PSPiergiorgio Solli
Piergiorgio Solli
Luca BertolacciniLuca Bertolaccini
Luca Bertolaccini
JBJury Brandolini
Jury Brandolini
APAlessandro Pardolesi
Alessandro Pardolesi
Although a rare occurrence, the need for diaphragmatic resection and reconstruction might be dictated by secondary invasion from different tumours, including lung cancer, mesothelioma, chest wall tumours, sarcomas and metastatic lesions. Additionally, the diaphragm plays an important role as structure for plastic or reconstructive surgery and its use as vascularised flap in thoracic surgery has been widely documented for the treatment of multiple conditions (i.e., reinforcement of spontaneous or iatrogenic oesophageal perforations, repair after extensive pericardial resection, prophylactic bronchial stump coverage or early closure of bronchopleural fistula). Some of the diaphragmatic resections can be repaired primarily, as long as there is adequate tissue that can be brought together without excessive tension. Larger defects or a completely resected diaphragm can be reconstructed only with synthetic or autologous tissue. The different techniques of resection and reconstruction are presented in a very detailed step-by-step format; the use of diaphragmatic flaps is widely discussed and a “tips and tricks” section is included in the final comments.

21 January 2023 in JTCVS Techniques
Verified
Journal Article
Open access
JBJury Brandolini
Jury Brandolini
PBPietro Bertoglio
Pietro Bertoglio
KKKenji Kawamukai
Kenji Kawamukai
BBBarbara Bonfanti
Barbara Bonfanti
SPSergio Nicola Forti Parri
Sergio Nicola Forti Parri
PSPiergiorgio Solli
Piergiorgio Solli

1 November 2017 in Annals of Translational Medicine
Verified
Journal Article
Closed access
PDF file
JBJury Brandolini
Jury Brandolini
Luca BertolacciniLuca Bertolaccini
Luca Bertolaccini
APAlessandro Pardolesi
Alessandro Pardolesi
PSPiergiorgio Solli
Piergiorgio Solli
Pulmonary neuroendocrine lung tumours are uncommon neoplasm; the presence of multiple and synchronous lesions is rare, and few case report are described in the literature. We present a case series of three patients without particular symptom and radiologic finding of multiple synchronous pulmonary nodules. All the patients underwent surgical treatment; histopathologic examination revealed typical carcinoid tumours in all three cases (one patient has a synchronous atypical carcinoid). No oncological progressions were observed at follow-up. A review of current literature is also presented with a suggested strategy management.

20 June 2022 in Monaldi Archives for Chest Disease
Verified
Journal Article
Open access
PDF file
JBJury Brandolini
Jury Brandolini
FAFrancesca Ambrosi
Francesca Ambrosi
PBPietro Bertoglio
Pietro Bertoglio
BBBarbara Bonfanti
Barbara Bonfanti
SFSergio Nicola Fortiparri
Sergio Nicola Fortiparri
PSPiergiorgio Solli
Piergiorgio Solli
Neurogenic tumors represent 10 to 34% of all mediastinal tumors and among them, neurofibroma originating from the vagus nerve are rare entities. We present a case of a neurofibroma with cystic degeneration originating from the left branch of the vagus nerve in a 27-years-old man without von Recklinghausen disease. A complete robotic resection of the mediastinal mass has been performed, with amputation of the vagus nerve enclosed in the mass. The postoperative course was uneventful and the patient was discharged in two days.

16 June 2026 in Cancers
Verified
Journal Article
Open access
PDF file
Giovanni LeuzziGiovanni Leuzzi
Giovanni Leuzzi
Filippo LococoFilippo Lococo
Filippo Lococo
BCBeatrice Cosentino
Beatrice Cosentino
FSFederica Sabia
Federica Sabia
MFMichele Ferrari
Michele Ferrari
PSPiergiorgio Solli
Piergiorgio Solli
Advances in screening, surgical techniques, perioperative care, and multimodality treatment have progressively expanded the population of long-term survivors with early-stage non-small cell lung cancer (NSCLC). However, disease-free survival does not necessarily correspond to complete functional recovery after curative-intent treatment. Many patients continue to experience persistent fatigue, dyspnea, reduced physical activity, impaired exercise tolerance, muscle loss, and deterioration in health-related quality of life despite adequate oncologic control. This narrative review discusses functional recovery as a survivorship endpoint in early-stage NSCLC, focusing on recovery trajectories, physiologic vulnerability, frailty, sarcopenia, rehabilitation, symptom burden, and emerging biologic frameworks such as allostatic load. Increasing evidence suggests that survivorship after NSCLC should not be interpreted exclusively according to recurrence or survival metrics, but also according to the ability to recover physiologic reserve, autonomy, and daily functioning after treatment. Functional recovery appears heterogeneous and influenced by multiple interacting factors, including baseline reserve, systemic inflammation, physical inactivity, behavioral adaptation, and cumulative stress burden. Rehabilitation strategies, structured symptom surveillance, and patient-reported outcomes may help identify vulnerable patients and improve long-term survivorship trajectories. Future survivorship models should probably integrate oncologic outcomes with longitudinal functional assessment to better characterize recovery patterns after treatment.